Search alternatives:
teer decrease » greater decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 mean » _ mean (Expand Search), a mean (Expand Search), i mean (Expand Search)
teer decrease » greater decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 mean » _ mean (Expand Search), a mean (Expand Search), i mean (Expand Search)
-
181
-
182
-
183
-
184
Decreasing NR1 and NR2A gene expression in 5-, 14- and 21-day groups.
Published 2017“…The expression of NR1 <b>(A)</b> and NR2A <b>(B)</b> in the hippocampus of each MMPM group showed a significant decrease compared with the control group.…”
-
185
EGCG decreases RSK2-mediated cell viability.
Published 2015“…Differences were evaluated using the Student’s t-test and the asterisk (*) indicates a significant decrease in viability in RSK2<sup>+/+</sup> MEFs compared to RSK2<sup>-/-</sup> MEFs (<i>p</i> < 0.05).…”
-
186
-
187
-
188
-
189
-
190
-
191
Activation of PAR2 decreased the frequency of mEPSCs.
Published 2016“…Co-application of TRPV1 antagonist SB 366791 (10 μM, 4 min, n = 8) or staurosporine (250 nM, 4 min, n = 10) prevented the inhibitory effect of SLIGKV-NH<sub>2</sub> (100 μM) treatment and the mean mEPSC values were statistically different compared to the application of SLIGKV-NH<sub>2</sub> alone (<sup>#</sup>p < 0.05, <sup>##</sup>p < 0.01).…”
-
192
-
193
-
194
-
195
Low concentrations of siRNA TMPRSS2-ERG III and IV impair TMPRSS2-ERG oncogene and oncoprotein levels but not cell viability.
Published 2015“…One hundred percent cell viability corresponds to the number of living cells incubated with transfecting agent only. Results are the mean ± SD of two independent experiments containing 8 replicates for each condition. * = <i>p</i><0.05, ** = <i>p</i><0.01, *** = <i>p</i><0.001, significant decrease compared to untreated cells (TA) or to siRNA Control (Kruskal & Wallis followed by Tukey and Dunnet test).…”
-
196
-
197
-
198
-
199
Ischemia decreased bcl-2 content in rabbit SSM.
Published 2015“…<u>Panel B:</u> Ratio of the intensity of bcl-2 over the intensity of subunit 4 of cytochrome oxidase was decreased in ischemia-damaged SSM compared to control (Mean ± SEM; *p<0.05 vs. control).…”
-
200